Open AccessP1171: REFLECT: PROSPECTIVE NON‐INTERVENTIONAL STUDY ON THE EFFECTIVENESS AND SAFETY OF SANDOZ RITUXIMAB (SDZ‐RTX) WITH CHOP FOR PATIENTS WITH PREVIOUSLY UNTREATED CD20‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Welslau M.,
Kubuschok B.,
Topaly J.,
Otremba B.,
Wolff T.,
Bryn G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847548.21824.f5
Subject(s) - medicine , rituximab , vincristine , diffuse large b cell lymphoma , prednisone , chop , clinical endpoint , cyclophosphamide , lymphoma , oncology , clinical trial , surgery , chemotherapy